Endocannabinoid system, pharmacogenomics and response to therapy

Pharmacogenomics

Volumn 11, Issue 7, 2010, Pages 907-910

  Onaivi, Emmanuel S ^a  

^a WILLIAM PATERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLGLYCEROL LIPASE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABIS; DRONABINOL; ENDOCANNABINOID; FATTY ACID AMIDASE; NABILONE; RIMONABANT;

ANOREXIA NERVOSA; ANXIETY; ATTENTION DEFICIT DISORDER; CANNABIS ADDICTION; CNR1 GENE; COPY NUMBER VARIATION; DEPRESSION; DRUG RESPONSE; EDITORIAL; EPIGENETICS; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEROIN DEPENDENCE; HUMAN; NAUSEA AND VOMITING; OBESITY; PARKINSON DISEASE; PERSONALIZED MEDICINE; PHARMACOGENOMICS; POSTTRAUMATIC STRESS DISORDER; SCHIZOPHRENIA; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDE;

DRUG DELIVERY SYSTEMS; ENDOCANNABINOIDS; HUMANS; PHARMACOGENETICS; POLYMORPHISM, GENETIC;

EID: 77954367966     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.10.91     Document Type: Editorial

References (22)

1. Onaivi ES, Suguira T, Di Marzo V (Eds): Endocannabinoids: The Brain and Body's Marijuana and Beyond. CRC Press, Taylor and Francis, London, UK; FL, USA 2006).
2. Taylor AH, Amoako AA, Banbang K et al.: Endocannabinoids and pregnancy. Clinica Chimica Acta 411(13-14), 921-930 (2010).
3. Onaivi ES, Ishiguro I, Lin Z: Cannabinoid receptor genetics and behavior. In: Biology of Marijuana: from Gene to Behavior. Onaivi ES (Ed.). Taylor and Francis, London, UK (2002).
4. Onaivi ES: Cannabinoid receptors in brain: Pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications. Int. Rev. Neurobiol. 88, 335-369 (2009).
5. Zhang P-W, Ishiguro H, Ohtsuki T et al.: Human cannabinoid receptor 1:5́ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse. Mol. Psychiatry 9, 916-931 (2004).
6. Ishiguro H, Iwasaki S, Teasenftz L et al.: Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans. Pharmacogenomics J. 7, 380-385 (2007).
7. Jesudason D, Witters G: Endocannabinoid system in food intake and metabolic regulation. Curr. Opin. Lipidol. 19, 344-348 (2008).
8. Hanus LO, Mechoulam R: Novel natural and synthetic ligands of the endocannabinoid system. Curr. Med. Chem. 17, 1341-1359 (2010).
9. Minkkila A, Saario SM, Nevalainen T: Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors. Curr. Med. Chem. 17, 828-858 (2010).
10. Robson P: Human studies of cannabinoids and medicinal cannabis. Handb. Exp. Pharmacol. 168, 719-756 (2005).
11. Ishiguro H, Horiuchi Y, Ishikawa M et al.: Brain CB2 receptor in schizophrenia. Biol. Psychiatry 67(10), 974-982 (2010).
12. Palomo T, Kostrzewa RM, Benninger RJ et al.: Genetic variation and spared biological susceptibility underlying comorbidity in neuropsychiatry. Neurotox. Res. 12, 29-42 (2007).
13. Benyamina A, Kebir O, Blecha L et al.: CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis. Addict. Biol. DOI: 10.1111/j.1369-1600.2009.00198.x (2010) (Epub ahead of print).
14. Proudnikov D, Krosiak T, Sipe JC et al.: Association of polymorphisms of cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes with heroin addiction: impact of long repeats of CNR1. Pharmacogenomics J. 10(3), 232-242 (2009).
15. Siegfried Z, Kanyas K, Latzer Y et al.: Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: differences between restricting and binging/purging subtypes. Am. J. Med. Genet. B Neuropsychiatr. Genet. 125, 126-130 (2004).
16. Barrero F J, Ampuero I, Morales B et al.: Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1). Pharmacogenomics J. 5, 135-141 (2005).
17. Lu AT, Ogdie MN, Jarvelin MJ et al.: Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder. Am. J. Med. Genet. Part B. 147B, 1488-1494 (2008).
18. Chavarria-Siles I, Contrras-Rojas J, Hare E et al.: Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia. Am. J. Med. Genet. 147, 279-284 (2008).
19. Karsak M, Cohen-Solal M, Freudenberg J et al.: Cannabinoid receptor type 2 gene is associated with human osteoporosis. Hum. Mol. Genet. 14, 3389-3396 (2005).
20. Yamada Y, Ando F, Shimkata H: Association of candidate gene polymorphisms with bone mineral density in community-dwelling Japanese women and men. Int. J. Mol. Med. 19, 791-801 (2007).
21. Sipe J C, Arbour N, Gerber A et al.: Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders. J. Leukoc. Biol. 78, 231-238 (2005).
22. Fowler CJ, Gustafsson SB, Chung SC et al.: Targeting the endocannabinoid system for treatment of cancer-a practical view. Curr. Top. Med. Chem. 10(8), 814-827 (2010).